EDGAR Filing Documents for 0001104659-15-049763

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001104659-15-049763

Filing Date

2015-07-06

Accepted

2015-07-06 12:48:34

Documents

Period of Report

2015-07-06

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	a15-15179_16k.htm	6-K	17322
2	EX-99.1	a15-15179_1ex99d1.htm	EX-99.1	24678
3	EX-99.2	a15-15179_1ex99d2.htm	EX-99.2	56617
4	EX-99.3	a15-15179_1ex99d3.htm	EX-99.3	9952
5	EX-99.4	a15-15179_1ex99d4.htm	EX-99.4	12896
6	GRAPHIC	g151791moi001.jpg	GRAPHIC	2938
7	GRAPHIC	g151791msi001.jpg	GRAPHIC	3789
8	GRAPHIC	g151791mmi001.jpg	GRAPHIC	2941
9	GRAPHIC	g151791mqi001.gif	GRAPHIC	5925
	Complete submission text file	0001104659-15-049763.txt		144509

Mailing Address ?STERGADE 24A, 1 COPENHAGEN G7 1100

Business Address ?STERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242

Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)